ClinicalTrials.gov
public full text
Public Domain
A Study of GB261 in Systemic Sclerosis
The purpose of this study is to assess the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of GB261 in patients with SSc.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.#1010134
- A Phase II Study of TollB-001 Tablets in Systemic Sclerosis#890286
- A1.13 Increased presence of CD206+ macrophage subset in peripheral blood of systemic sclerosis patients#334334
- Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients#866297
- SPIN Self-Management Feasibility Trial#882512
Record · ID 876047
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive